(313 days)
The Transnasal Lacrimal Stent is indicated in treatments of epiphora treated by dacryocystorhinostomy. Dacryocystorhinostomy (DCR) is the common surgical procedure used to correct nasolacrimal duct obstruction.
Not Found
The provided document is a 510(k) substantial equivalence letter for the Becker Transnasal Lacrimal Stent. It does not contain information about acceptance criteria or specific study details proving device performance. The letter confirms that the FDA has determined the device is substantially equivalent to legally marketed predicate devices.
Therefore, I cannot provide the requested information from this document. The document primarily focuses on regulatory approval based on substantial equivalence rather than detailed performance study results.
N/A